Neumora Therapeutics, Inc. (NMRA) stock
NMRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.43−0.00 (-0.95%)
Close on Nov 13, 2026Market cap $80.59MP/E –Yield –
Neumora Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Neumora Therapeutics's market cap was $82.24M on Nov 11, 2026, against $361.75M a year earlier. Over the last 3 years it ranged from $63.84M to $2.80B, with a median of $314.09M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $82.24M | -71.6% |
| 2025 | Dec 31, 2025 | $289.07M | -80.0% |
| 2024 | Apr 30, 2024 | $1.44B | +152.0% |
| 2023 | Dec 29, 2023 | $572.87M | – |
See a number that looks wrong?